THE CONAFAY GROUP, LLC

Lobbying for REVAGENIX, INC. · Biopharmaceutical company creating anti-infective medicines.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 17, 2025

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Opportunities to promote antimicrobial drug development.

Health Issues

Opportunities to promote antimicrobial drug development.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.